• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

878例肝细胞癌患者中吲哚菁绿潴留率对射频消融并发症的预测价值

Predictive value of indocyanine green retention rate with respect to complications of radiofrequency ablation in 878 patients with hepatocellular carcinoma.

作者信息

Tang Tengqian, Feng Xiaobin, Yan Jun, Xia Feng, Li Xiaowu, Ma Kuansheng, Bie Ping

机构信息

Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University , Chongqing , China.

出版信息

Int J Hyperthermia. 2014 Sep;30(6):402-7. doi: 10.3109/02656736.2014.951404.

DOI:10.3109/02656736.2014.951404
PMID:25256893
Abstract

BACKGROUND AND AIMS

Radiofrequency ablation (RFA) is a minimally invasive technique used for the treatment of hepatocellular carcinoma (HCC). It may produce complications. The indocyanine green (ICG) retention rate at 15 min (ICGR15) has been used to predict complications after hepatectomy. In this study, the prediction of the value of ICGR15 for complications of RFA to the patients with HCC was evaluated.

METHODS

Some 878 cases of HCC treated between June 2009 and June 2013 were evaluated. All patients were treated by percutaneous radiofrequency ablation. Patients were divided into two groups: a complication group (85 cases) and a complication-free group (793 cases). ICGR15 and other baseline characteristics of the two groups were compared. A logistic regression model was used to analyse the merits of assessing liver reserve to predict complications post-RFA.

RESULTS

Complications such as intra-abdominal haemorrhage and pleural effusion occurred in 85 (9.68%) patients after RFA. Patients in the two groups did not differ with regard to baseline parameters. Patients in the two groups did differ significantly in ICGR15 and tumour site (p < 0.05). Tumour site was found to have a significant impact on the rate of complications post-RFA. There was no significant difference in ICGR15 values among patients with the same Child-Pugh scores or in the same tumour site.

CONCLUSIONS

The present results demonstrated that RFA is minimally invasive and suitable for the treatment of HCC. They also showed that ICGR15 did not independently predict for liklihood of post-RFA complications, after controlling for tumour site. Patients with tumours located subcapsularly or near the porta hepatis were found to have significantly higher rates of post-operative complications after RFA than to patients with tumours in the liver parenchyma.

摘要

背景与目的

射频消融术(RFA)是一种用于治疗肝细胞癌(HCC)的微创技术。它可能会产生并发症。15分钟吲哚菁绿(ICG)滞留率(ICGR15)已被用于预测肝切除术后的并发症。在本研究中,评估了ICGR15值对HCC患者RFA并发症的预测价值。

方法

对2009年6月至2013年6月间治疗的878例HCC患者进行评估。所有患者均接受经皮射频消融治疗。患者分为两组:并发症组(85例)和无并发症组(793例)。比较两组的ICGR15及其他基线特征。采用逻辑回归模型分析评估肝脏储备以预测RFA术后并发症的优点。

结果

RFA术后85例(9.68%)患者出现腹腔内出血、胸腔积液等并发症。两组患者的基线参数无差异。两组患者的ICGR15和肿瘤部位有显著差异(p<0.05)。发现肿瘤部位对RFA术后并发症发生率有显著影响。相同Child-Pugh评分或相同肿瘤部位的患者ICGR15值无显著差异。

结论

目前结果表明,RFA具有微创性,适用于HCC的治疗。结果还表明,在控制肿瘤部位后,ICGR15不能独立预测RFA术后并发症的可能性。发现位于肝包膜下或肝门附近的肿瘤患者RFA术后的并发症发生率明显高于肝实质内肿瘤患者。

相似文献

1
Predictive value of indocyanine green retention rate with respect to complications of radiofrequency ablation in 878 patients with hepatocellular carcinoma.878例肝细胞癌患者中吲哚菁绿潴留率对射频消融并发症的预测价值
Int J Hyperthermia. 2014 Sep;30(6):402-7. doi: 10.3109/02656736.2014.951404.
2
Efficacy and feasibility of radiofrequency ablation for hepatocellular carcinoma patients.射频消融治疗肝细胞癌患者的疗效与可行性
Hepatogastroenterology. 2012 Nov-Dec;59(120):2540-2. doi: 10.5754/hge12128.
3
Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.射频消融作为小的单发肝细胞癌的一线治疗:长期结果。
Eur J Surg Oncol. 2010 Nov;36(11):1054-60. doi: 10.1016/j.ejso.2010.08.133. Epub 2010 Sep 16.
4
Kinetics of indocyanine green removal from blood can be used to predict the size of the area removed by radiofrequency ablation of hepatic nodules.吲哚菁绿从血液中清除的动力学可用于预测肝结节射频消融切除区域的大小。
J Gastroenterol Hepatol. 2006 Nov;21(11):1714-9. doi: 10.1111/j.1440-1746.2006.04417.x.
5
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.射频消融与手术切除治疗小肝癌的随机对照研究。
J Hepatol. 2012 Oct;57(4):794-802. doi: 10.1016/j.jhep.2012.05.007. Epub 2012 May 23.
6
[Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].[肝细胞癌肝切除术前通过ICGR15检测评估肝脏储备功能]
Ai Zheng. 2004 Oct;23(10):1213-7.
7
Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma.射频消融与肝切除术治疗小肝细胞癌的长期疗效和并发症比较。
J Gastroenterol Hepatol. 2014 Jan;29(1):193-200. doi: 10.1111/jgh.12441.
8
Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test.吲哚菁绿清除试验结果不理想的肝细胞癌患者行肝大部切除术。
Br J Surg. 1999 Aug;86(8):1012-7. doi: 10.1046/j.1365-2168.1999.01204.x.
9
Evaluation of liver function for hepatic resection for hepatocellular carcinoma in the liver with damaged parenchyma.对肝实质受损的肝脏中肝细胞癌肝切除术的肝功能评估。
J Surg Res. 2004 Feb;116(2):248-52. doi: 10.1016/j.jss.2003.09.015.
10
Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.使用吲哚菁绿提取法预测肝细胞癌立体定向体部放射治疗后的肝功能
Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):131-137. doi: 10.1016/j.ijrobp.2017.09.032. Epub 2017 Sep 22.

引用本文的文献

1
Sequential Portal Vein Embolization and Percutaneous Radiofrequency Ablation for Future Liver Remnant Growth: A Minimally Invasive Alternative to ALPPS Stage-1 in Treatment of Hepatocellular Carcinoma.序贯门静脉栓塞与经皮射频消融促进未来肝残余体积增长:一种治疗肝细胞癌的微创替代ALPPS一期手术的方法
Front Surg. 2021 Sep 30;8:741352. doi: 10.3389/fsurg.2021.741352. eCollection 2021.
2
A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.使用吲哚菁绿的经动脉化疗栓塞治疗巴塞罗那临床肝癌分期 C 期肝癌的新策略。
Cancer Med. 2020 Jan;9(1):62-76. doi: 10.1002/cam4.2671. Epub 2019 Nov 8.
3
Laparoscopic versus open mesohepatectomy for patients with centrally located hepatocellular carcinoma: a propensity score matched analysis.
腹腔镜与开腹肝中叶切除术治疗中央型肝细胞癌的疗效比较:倾向评分匹配分析。
Surg Endosc. 2019 Sep;33(9):2916-2926. doi: 10.1007/s00464-018-6593-2. Epub 2018 Nov 29.
4
Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma.射频消融联合经动脉化疗栓塞治疗特殊部位小肝癌
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818788529. doi: 10.1177/1533033818788529.
5
Laparoscopic Radiofrequency Ablation Should Be Considered a Safe Treatment for Hepatocellular Carcinoma Patients with Severe Cirrhosis and Impaired ICG-15 Test.对于伴有严重肝硬化且吲哚菁绿15分钟滞留率(ICG-15)试验结果不佳的肝细胞癌患者,腹腔镜射频消融术应被视为一种安全的治疗方法。
Dig Dis Sci. 2015 Jul;60(7):2201-2. doi: 10.1007/s10620-015-3550-y. Epub 2015 Jan 29.